Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of March 2019. The report details a capital increase approved by the Board of Directors on March 25, 2019, resulting from the exercise of stock options under the Company's 2019 Stock Option Plan.
Key Financial Metrics
The filing does not provide standard operating financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data presented relates exclusively to the capital increase transaction:
- Capital Increase Amount: BRL 9,599,613.21
- New Capital Stock: BRL 57,719,801,527.98
- Shares Issued: 570,387 new common shares (no par value)
- Issuance Price: BRL 16.83 per share
- Potential Dilution: 0.00363%
Material Changes
The primary material change is the increase in authorized capital stock and the issuance of 570,387 new common shares. The filing includes historical stock price data (adjusted for dividends and interest on equity) for the preceding three years, two years by quarter, and six months by month, but does not report material changes in operational performance compared to prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It is a procedural notice regarding the homologation of a capital increase pursuant to Brazilian Securities and Exchange Commission Normative Ruling No. 480/09.
Investor Verification Checklist
- Verify the impact of the 0.00363% dilution on existing shareholder equity.
- Confirm the total number of outstanding shares post-issuance (New Capital Stock: BRL 57,719,801,527.98).
- Review the historical stock price trends provided to assess the issuance price (BRL 16.83) relative to the 90-day average (BRL 17.44) and March 2019 average (BRL 16.88).
- Note that this filing does not contain Q1 2019 operational results; refer to the Company's Form 20-F or quarterly reports for financial performance.